Skip to main content
Log in

Pituitary carcinomas

  • Review
  • Published:
Endocrine Pathology Aims and scope Submit manuscript

Abstract

Pituitary carcinomas are defined by their metastatic growth. Most of them also invade into surrounding tissues. They should be classified by the site of their metastases (cerebrospinal, systemic, or combined) and by the presumable cell type of origin, respectively with the hormone being demonstrable by immunohistochemistry (adrenocorticotrophic hormone [ACTH], prolactin [PRL], growth hormone [GH], hormone-negative). Pituitary carcinomas develop from invasive adenomas. Nearly all tumors had been treated by surgery or X-ray before they metastasized. Since 1976, 37 cases demonstrated with modern methods were reported: 23 had metastasized into the brain or meninges, 10 showed extracerebral metastases, and 4 showed both types of metastases. In our collection of pituitary tumors, three carcinomas (0.13%) were identified: two with systemic metastases (one ACTH secreting and one PRL secreting) and one with meningeal dissemination and ACTH production. The diagnosis of pituitary carcinomas should be based on four criteria: a demonstrable metastasis, identification of the primary tumor as a pituitary tumor, similarity between the structure and immunohistological marker expression of metastsis and primary tumor, and exclusion of an alternative primary tumor.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hedinger C, Williams ED, Sobin LH. Histological typing of thyroid tumours. 2nd ed. Berlin: Springer Verlag, 1988; 1–66.

    Google Scholar 

  2. Capella C, Heitz Ph, Höfler H, Solcia E. Revised classification of neuroendocrine tumours of the lung, pancreas and gut. Virchows Arch 425:547–560, 1995.

    Article  PubMed  CAS  Google Scholar 

  3. Sautner D, Saeger W. Invasiveness of pituitary adenomas. Pathol Res Pract 187:632–636, 1991.

    PubMed  CAS  Google Scholar 

  4. Selman WR, Laws ER, Scheithauer BW, Carpenter SM. The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402–406, 1986.

    PubMed  CAS  Google Scholar 

  5. Cagnetto G. Zur frage der anatomischen beziehung zwischen akromegalie und hypophysentumoren. Virchows Arch. 176:115–169, 1904.

    Article  Google Scholar 

  6. Stolpe R. Deutsche gesellschaft für Chirurgie 33. Kongr Dtsch Med Wochenschr 30:696, 1904.

    Google Scholar 

  7. Smoler F. Zur operation der hypophysentumoren auf nasalem Wege. Wien Klin Wochenschr 13:1488, 1489, 1909.

    Google Scholar 

  8. Fahr Th. Beiträge zur pathologie der hypophyse. Dtsch Med Wochenschr 44:206–211, 1918.

    Article  Google Scholar 

  9. Budde M. Zur Kenntnis der bösartigen hypophysengeschwülste und hypophysärer kachexie. Fr Z Pathol 25:16–34, 1921.

    Google Scholar 

  10. Vasiliu T. Durch ein hypophysenadenom hervorgerufene multiple knochenmetastasen. Virchows Arch 276:141–146, 1930.

    Article  Google Scholar 

  11. Cairns H, Russell D. Intracranial and spinal metastases in gliomas of the brain. Brain Liv 377–421, 1931.

  12. Gilmour MD. Carcinoma of the pituitary gland with abdominal metastases. J Pathol 35:264–266, 1932.

    Article  Google Scholar 

  13. Kontchakova M. Metastasen von tumoren der hypophyse, ihre pathologische anatomie und ihre klinik. Zentralbl Gesamte Neurol 86:572(Abstract), 1936.

    Google Scholar 

  14. Scholz DA, Gastineau CF, Harrision EG. Cushing’s syndrome with malignant chromophobe tumour of the pituitary and extracranial metastasis: report of case. Am J Med 17:34–41, 1962.

    Google Scholar 

  15. Cohan H, Dibble H. Pituitary basophilism associated with a basophil carcinoma of the anterior lobe of the pituitary gland. Brain 59:395–407, 1936.

    Article  Google Scholar 

  16. Köhlmeier W. Zur kenntnis der metastasienden hypophysengeschwülste. Virchows Arch 312:26–34, 1944.

    Article  Google Scholar 

  17. Forbes W. Carcinoma of the pituitary gland with metastases to the liver in a case of Cushing’s syndrome. J Pathol Bacteriol 59:137–144, 1947.

    Article  Google Scholar 

  18. Feiring EH, Davidoff LM, Zimmermann HM. Primary carcinoma of the pituitary. J Neuropathol Exp Neurol 12:205–222, 1953.

    PubMed  CAS  Google Scholar 

  19. Sheldon WH, Goden A, Bondy PK. Cushing’s syndrome produced by a pituitary basophil carcinoma with hepatic metastases. Am J Med 17:134–142, 1954.

    Article  PubMed  CAS  Google Scholar 

  20. Moberg A. A case of pituitary chromophobe adenoma with metastases of the heart. Acta Pathol Microbiol 45:243–249, 1959.

    Google Scholar 

  21. Salassa RM, Kearns TP, Kernohan JW, Sprague RG, MacCarthy SS. Pituitary tumours in patients with Cushing’s syndrome. J Clin Endocrinol Metab 19:1523–1539, 1959.

    PubMed  CAS  Google Scholar 

  22. Graf CJ, Blinderman EE, Terplan KL. Pituitary carcinoma in a child with distant metastases. J Neurosurg 19:154–159, 1962.

    Google Scholar 

  23. Newton TH, Burhenne HJ, Palubinskas J. Primary carcinoma of the pituitary. Am J Roentgenol 87:110–119, 1962.

    CAS  Google Scholar 

  24. Madonick MJ, Rubinstein LJ, Dasco MR, Ribner H. Chromophobe adenoma of pituitary gland with subarachnoidal metastases. Neurology 13:836–840, 1963.

    PubMed  CAS  Google Scholar 

  25. Epstein JA, Epstein BS, Molho L, Zimmerman HM. Carcinoma of the pituitary gland with metastases to the spinal cord and roots of the cauda equina. J Neurosurg 21:847–853, 1964.

    Google Scholar 

  26. Braun W, Tzonos T. Über ein ungewöhnlich rasch wachsendes hypophysencarcinom mit intracerebralen metastasen. Acta Neurochir Wien 12:615–624, 1965.

    Article  PubMed  CAS  Google Scholar 

  27. Solitare GB, Jatlow P. Adenohypophysial carcinoma. J Neurosurg 26:624–631, 1967.

    PubMed  CAS  Google Scholar 

  28. Geroulanos S. Chromophobes hypophysenadenom mit leber- und knochenmetastasen. Schweiz Med Wochenschr 99: 1817–1824, 1969.

    PubMed  CAS  Google Scholar 

  29. Fleischer AS, Reagan T, Ransohoff J. Primary carcinoma of the pituitary with metastasis to the brainstem. J Neurosurg 36:781–784, 1972.

    PubMed  CAS  Google Scholar 

  30. D’Abrera VSE, Burke WJ, Bleasel KF, Bader L. Carcinoma of the pituitary gland. J Pathol 109:335–343, 1973.

    Article  PubMed  CAS  Google Scholar 

  31. Ogilvy KM, Jakubowski J. Intracranial dissemination of pituitary adenomas. J Neurol Neurosurg Psychiatry 36:199–205, 1973.

    PubMed  CAS  Google Scholar 

  32. Ricoy J, Carrillo R, Bravo G. Dissemination of pituitary adenomas. Acta Neurochirurgica 31:123–130, 1974.

    Article  Google Scholar 

  33. Queiroz LS de, Facure NO, Facure JJ, Modesro NP, Faria JL. Pituitary carcinoma with liver metastases and Cushing’s syndrome. Arch Pathol 99:32–35, 1975.

    Google Scholar 

  34. Martin NA, Hales M, Wilson CB. Cerebellar metastasis from a prolactinoma during treatment with bromocriptine. J Neurosurg 55:615–619, 1981.

    Article  PubMed  CAS  Google Scholar 

  35. Cohan DL, Diengdoh JV, Thomas DGT, Himsworth RL. An intracranial metastasis from a PRL-secreting pituitary tumour. Clin Endocrinol Oxford 18:259–264, 1983.

    Google Scholar 

  36. Duskova J, Chlumska A, Vilikusova E, Marek J, Spincl L. Pituitary carcinoma with acromegaly. Cesk Pathol 20:170–176, 1984.

    CAS  Google Scholar 

  37. Gatti G, Limone P. ACTH-producing hypophyseal carcinoma monitored by computed tomography. Diagn Imag Clin Med 53:292–297, 1984.

    CAS  Google Scholar 

  38. Zafar MS, Mellinger RC, Chason JL. Cushing’s disease due to pituitary carcinoma. Henry Ford Hosp Med J 32:61–66, 1984.

    PubMed  CAS  Google Scholar 

  39. Hoi Sung U, Johnson C. Metastatic prolactin-secreting pituitary adenoma. Hum Pathol 15:90–96, 1984.

    Google Scholar 

  40. Papotti M, Limone P, Riva C, Gatti G, Bussolati G. Malignant evolution of an ACTH-producing tumor treated with intrasellar implantation of 90 Y. Appl Pathol 2:10–21, 1984.

    PubMed  CAS  Google Scholar 

  41. Plangger CA, Twerdy K, Grunert V, Weiser G. Subarachnoid metastases from a prolactinoma. Neurochirurgica 28:235–237, 1985.

    CAS  Google Scholar 

  42. Gasser RW, Finkenstedt G, Skrabel F, Twerdy K, Grundert V, Mayr U, Frommhold H, Nedden D, Feichtinger J, Hofstädter F. Multiple intracranial metastases from a prolactin-secreting pituitary tumour. Clin Endocrinol 22:17–27, 1985.

    CAS  Google Scholar 

  43. Landgraf R, Rieder G, Schmiedek P, Clados D, Bise K, von Werder K. Hormone—active intradural spinal metastasis of a prolactinoma—a case report. Klin Wochenschr 63:379–384, 1985.

    Article  PubMed  CAS  Google Scholar 

  44. Hashimoto N, Handa H, Nishi S. Intracranial and intraspinal dissemination from a growth hormone-secreting pituitary tumor. J Neurosurg 64:140, 1986.

    PubMed  CAS  Google Scholar 

  45. Asai A, Matsutani M, Funada N, Takakura K. Malignant growth hormone-secreting pituitary adenoma with hematogenous dural metastasis: case report. Neurosurgery 22: 1091–1094, 1988.

    Article  PubMed  CAS  Google Scholar 

  46. Muhr C, Bergström M, Lundberg PO, Hartmann M, Bergström K, Pellettieri L, Langström B. Malignant prolactinoma with multiple intracranial metastases studied with positron emission tomography. Neurosurtery 22:374–379, 1988.

    CAS  Google Scholar 

  47. Sakamoto T, Itoh Y, Fushimi S, Kowada M, Saito M. Primary pituitary carcinoma with spinal cord metastasis care report. Neurol Med Chir Tokyo 30(10):763–767, 1990.

    PubMed  CAS  Google Scholar 

  48. Levesque H, Freger P, Gancel A, Tayot J, Cortois H. Carcinoma primitif de l’hypophyse avec syndrome de Cushing et metastases. A propos d’un cas avec revue à la litterature. Rev Med Interne 12:209–212, 1991.

    PubMed  CAS  Google Scholar 

  49. Popvic EA, Vattuone JR, Siu KH, Busmanis I, Pullar MJ, Dowling J. Malignant prolactinomas. Neurosurgery 29:127–130, 1991.

    Article  Google Scholar 

  50. Kouhara H, Tatekewa T, Koga M, Hiraga S, Arita N, Mori H, Sato B. Intracranial and intraspinal dissemination of an ACTH-secreting pituitary tumour. Endocrinol Jpn 39:177–184, 1992.

    PubMed  CAS  Google Scholar 

  51. Stewart PM, Cary MP, Graham CT, Wright AD. Growth hormone secreting pituitary carcinoma: a case report and literature review. Clin Endocrinol 37:189–195, 1992.

    CAS  Google Scholar 

  52. Tonner D, Belding P, Moore SA, Schlechte JA. Intracranial dissemination of an ACTH-secreting-pituitary neoplasm—a case report and review of the literature. J Endocrinol Invest 15:387–391, 1992.

    PubMed  CAS  Google Scholar 

  53. Kamphorst W, Wolbers JG, Ponssen H, Karim ABMF. Ectopic parasellar pituitary adenoma with subarachnoid seeding. J Neurol Neurosurg Psychiatry 55:73,74, 1992.

    PubMed  CAS  Google Scholar 

  54. Taylor WA, Uttley D, Wilkins PR. Multiple dural metastases from a pituitary adenoma—case report. J Neurosurg 81:624–626, 1994.

    PubMed  CAS  Google Scholar 

  55. Lübke D, Saeger W, Lüdecke DK. Proliferation markers and EGF in ACTH-secreting adenomas and carcinomas of the pituitary. Endocr Pathol 6:45–55, 1995.

    PubMed  Google Scholar 

  56. Kaiser FE, Orth DN, Mukai K, Oppenheimer HJ. A pituitary parasellar tumour with extracranial metastases and high, partially suppressible levels of adrenocorticopin and related peptides. J Clin Endocrinol Metab 57:649–653, 1983.

    PubMed  CAS  Google Scholar 

  57. Myles ST, Johns RD, Curry B. Clinicopathological conference: carcinoma of the pituitary gland with metastases to bone. Can J Neurol Sci 11:310–317, 1984.

    PubMed  CAS  Google Scholar 

  58. Nudleman KL, Choi B, Kusske JA. Primary pituitary carcinoma: a clinical pathological study. Neurosurgery 16:379–384, 1985.

    Article  Google Scholar 

  59. Scheithauer BW, Randall RV, Laws ER, Kovacs KT, Horvath E, Whitaker MD. Prolactin cell carcinoma of the pituitary. Cancer 55:598–604, 1985.

    Article  PubMed  CAS  Google Scholar 

  60. Casson IF, Walker BA, Hipkin LJ, Davis JL, Buxton OH, Jeffreys RV. An intrasellar pituitary tumor producing metastases in liver, bone and lymph glands and demonstration of ACTH in the metastatic deposits. Acta Endocrinol Copenh 111:300–304, 1986.

    PubMed  CAS  Google Scholar 

  61. Walker JD, Grossman A, Anderson JV, Ur E, Trainer PJ, Benn J, Lowy C, Sonkson PH, Plowman PN, Lowe DG, Doniach I, Wass JAH, Besser GM. Malignant prolactinoma with extracranial metastases—a report of three cases. Clin Endocrinol 4:411–419, 1993.

    Google Scholar 

  62. Saeger W, Bosse U, Pfingst E, Schierke G, Kulinna H, Atkins D, Gullotta F. Prolactin bildendes hypophysencarcinom. Kasuistik eines äußerst seltenen metastasierenden tumors. Pathologe 16:354–358, 1995.

    Article  PubMed  CAS  Google Scholar 

  63. Gabrilove JL, Anderson PJ, Halmi NS. Pituitary pro-opiomelanocortin-cell carcinoma occurring in conjunction with a glioblastoma in a patient with Cushing’s disease and subsequent Nelson’s syndrome. Clin Endocrinol 22:17–27, 1986.

    Google Scholar 

  64. Luzi P, Miracco C, Lio R, Malandrni A, Piovani S, Venezia SG, Tosi P. Endocrine inactive pituitary carcinoma metastasizing to cervical lymph nodes: a case report. Hum Pathol 18:90–92, 1987.

    Article  PubMed  CAS  Google Scholar 

  65. Atienza DM, Vigersky RJ, Lack EE, Carriaga M, Runwock J, Tsou E, Cerrone F, Kattah JG, Sausville EA. Prolactin-producing pituitary carcinoma with pulmonary metastases. Cancer 68:1605–1610, 1991.

    Article  PubMed  CAS  Google Scholar 

  66. Mixson AJ, Friedman TC, Katz DA, Feuerstein IM, Taubenberger JK, Colandrea JM, Doppman JL, Oldfield EH, Weintraub BD. Thyrotropin-secreting pituitary carcinoma. J Clin Endocrinol Metab 87:529–533, 1993.

    Article  Google Scholar 

  67. Lyons J, Landis CA, Harsh G, Vallar L, Grunewald K, Feichtiger H, Duh Q, Clark OH, Kawasaki E, Bourne HR, McCormick F. Two G protein oncogenes in human endocrine tumors. Science 249:655–659, 1990.

    Article  PubMed  CAS  Google Scholar 

  68. Spada A, Vallar L, Faglia G. G-proteins and hormonal signalling in human pituitary tumors—genetic mutations and functional alternations. Front Neuroendocrinol 14:214–232, 1993.

    Article  PubMed  CAS  Google Scholar 

  69. Karga HJ, Alexander JM, Hedley-Whyte ET, Klibanski A, Jameson JL. Ras mutation in human pituitary tumors. Clin Endocrinol Metab 74:914–919, 1992.

    Article  CAS  Google Scholar 

  70. Pei L, Melmed S, Scheithauter BW, Kovacs K, Prager D. H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78:842–846, 1994.

    Article  PubMed  CAS  Google Scholar 

  71. U HS, Kelley P, Lee WH. Abnormalities of the human growth hormone gene and protooncogenes in some human pituitary adenomas. Mol Endocrinol 2:85–89, 1988.

    PubMed  CAS  Google Scholar 

  72. Woloschak M, Robert JL, Post K. c-myc, c-fos, c-myb gene expression in human pituitary adenomas. J Clin Endocrinol Metab 79:253–257, 1994.

    Article  PubMed  CAS  Google Scholar 

  73. Pei L, Melmed S, Scheithauer BW, Kovacs K, Benedict WF, Prager D. Frequent loss of heterozygosity at the retinoblastoma gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB. Cancer Res 55:1613–1616, 1995.

    PubMed  CAS  Google Scholar 

  74. Bystrom C, Larsson C, Blomberg C, Sandelin K, Falkmer E, Skogseid B, Oberg K, Werner S, Nordenskjold M. Localization of the MEN 1 gene to a small region within chromosome 11q13 by deletion mapping in tumors. Proc Natl Acad Sci USA 87:1968–1972, 1990.

    Article  PubMed  CAS  Google Scholar 

  75. Thakker RV, Pook MA, Wooding C, Boscaro M, Scanarini M, Clayton RN. Association of somatotropinomas with loss of alleles on chromosome 11 and with gsp mutations. J Clin Invest 91:2815–2821, 1993.

    PubMed  CAS  Google Scholar 

  76. Gonsky R, Herman V, Melmed S, Fagin J. Transforming DNA sequences present in human prolactin-secreting pituitary tumors. Mol Endocrinol 5:1687–1695, 1991.

    PubMed  CAS  Google Scholar 

  77. Wetherall MRB, Corbett IP, Ince P, James RA, Daniels M, Harris PE, Hendall-Taylor P. Human pituitary adenomas do not overexpress the c-erbB-2 oncoprotein. Endocr Pathol 2:210–213, 1991.

    Google Scholar 

  78. Tsagarakis S, Kontogeorgos G, Giannou P, Thalassinos N, Woolley J, Besser GM, Grossman A. Interleukin-6, a growth promoting cytokine, is present in human pituitary adenomas—an immunocytochemical study. Clin Endocrinol 37:163–167, 1992.

    CAS  Google Scholar 

  79. Alvaro V, Touraine P, Vozari RR, Baigrenier F, Birman P, Joubert D. Protein kinase-C activity and expression in normal and adenomatous human pituitaries. Cancer 50:724–730, 1992.

    CAS  Google Scholar 

  80. Sumi T, Stefaneanu L, Kovacs K, Asa SL, Rindi G. Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr. Pathol. 4:95–99, 1993.

    Article  Google Scholar 

  81. Buckley N, Bates AS, Broome JC, Strange RC, Perrett CW, Burke CW, Clayton RN. P53 protein accumulates in Cushing’s adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 80:692, 1995.

    Article  Google Scholar 

  82. Inada K, Oda Y, Utsunomiya H, Sanno N, Itoh J, Osamura RY, Voss JW, Rosenfeld MG. Immunohistochemical expression of Pit-1 protein in human pituitary adenomas. Endocr Pathol 4:201–204, 1993.

    Google Scholar 

  83. Dietrich CU, Pandis N, Bjerre P, Schroder HD, Heim S. Simple numerical chromosome aberrations in two pituitary adenomas. Cancer Genet Cytogenet 69:118–121, 1993.

    Article  PubMed  CAS  Google Scholar 

  84. Herman V, Fragin J, Gonsky R, Kovacs K, Melmed S. Clonal origin of pituitary adenomas. J Clin Endocrinol Metab 71:1427–1433, 1990.

    Article  PubMed  CAS  Google Scholar 

  85. Gicquel C, Lebouc Y, Craig J, Luton JP, Girard F, Bertagna X. Pituitary corticotroph adenomas are monoclonal. 73rd Annual Meeting of the Endocrine Society, Washington, DC, 1636 (abstract), 1991.

  86. Jacks T, Fazeli A, Schmitt EM, Bronson RT, Goodell MA, Weinberg RA. Effects of an Rb mutation in the mouse. Nature 359: 295–300, 1992.

    Article  PubMed  CAS  Google Scholar 

  87. Landolt AM, Shibata T, Kleihues P. Growth rate of human pituitary adenomas. J Neurosurg 67:803–806, 1987.

    PubMed  CAS  Google Scholar 

  88. Shibuya M, Saito F, Miwa T, Davis RL, Wilson CB, Hoshino T. Histochemical study of pituitary adenomas with Ki67 and anti-DNA polymerase alpha monoclonal antibodies, bromodeoxy-uridine labeling, and nucleolar organizer region counts. Acta Neuropathol 84:178–183, 1992.

    Article  PubMed  CAS  Google Scholar 

  89. Tsanaclis AM, Robert F, Michaud, J, Brem S. The cycling pool of cells within human brain tumours: in situ cytokinetics using the monoclonal antibody Ki-67. Can J Neurol Sci 18:12–17, 1991.

    PubMed  CAS  Google Scholar 

  90. Hsu DW, Hakim F, Biller BMK, Delamonte S, Zervas NT, Klibanski A, Hedleywhyte ET. Significance of proliferating cell nuclear antigen index in predicting pituitary adenoma recurrence. J Neurosurg 78:753–761, 1993.

    PubMed  CAS  Google Scholar 

  91. McNicol AM, Sheperd M, Lane OP. Cell proliferation in pituitary adenomas; correlation with hormonal immunoreactivity. Abstract 14. J Endocrinol Invest 14(Suppl. 1): 55, 1991.

    Google Scholar 

  92. Pernicone PJ, Scheithauer BW. Invasive pituitary adenomas and pituitary carcinomas. In: Lloyd RV, ed. Surgical pathology of the pituitary gland. Major problems in pathology. vol 27. Philadelphia, PA: Saunders, 1993: 121–136.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saeger, W., Lübke, D. Pituitary carcinomas. Endocr Pathol 7, 21–35 (1996). https://doi.org/10.1007/BF02739912

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02739912

Key Words

Navigation